admisiones@uees.edu.ec (04) 500 0950 Centro de Ayuda
Admisiones 2025
oscardelbrutto@hotmail.com
Perfil de Google Scholar

Oscar del Brutto

Investigador

Es Director, de Proyecto Atahualpa Project, Atahualpa, Ecuador (2012 al momento), Profesor de Neurología, Facultad de Medicina, Universidad Espíritu Santo – Ecuador (2012 al momento), Neurólogo del Departamento de Ciencias Neurológicas, Hospital-Clínica Kennedy, Guayaquil, Ecuador (1989 al momento).

Dirección

Hospital-Clínica Kennedy, Sección Delta, Oficina S-7, Calle 9na s/n y Avenida San Jorge, Guayaquil, Ecuador; y Centro de Investigación, Universidad Espíritu Santo – Ecuador, Km 3, Vía Puntilla-Samborondón, Ecuador

Educación

  • Doctor en Medicina y Cirugía (M.D.), Facultad de medicina, Universidad Católica de Santiago de Guayaquil (1976-1984).
  • Especialista en neurología, Universidad Nacional Autónoma de México (1989).
  • Residencia de Neurología, Instituto nacional de Neurología y Neurocirugía de México (1986-1989).

Lineas de investigación

  • Salud.

Artículos publicados

Revistas indexadas en PubMED/MEDLINE:

  1. Low prevalence of atrial fibrillation in Amerindians: a population-based study in frequent fish consumers living in rural coastal Ecuador (The Atahualpa Project). Del Brutto OH, Costa AF, Cano JA, Peñaherrera E, Plaza KJ, Ledesma EA, Tettamanti D, Zambrano M. Aging Clin Exp Res. 2017 Jul 31. doi: 10.1007/s40520-017-0810-z. [Epub ahead of print]
  2. Antiparasitic treatment of neurocysticercosis – The effect of cyst destruction in seizure evolution. Garcia HH, Del Brutto OH; Cysticercosis Working Group in Peru. Epilepsy Behav. 2017 Jun 9. pii: S1525-5050(17)30019-7. doi: 10.1016/j.yebeh.2017.03.013. [Epub ahead of print] Review.
  3. Letter re: Teaching NeuroImages: Giant neurocysticercosis with unusual imaging manifestations. Del Brutto OH. Neurology. 2017 Jun 6;88(23):2238. doi: 10.1212/WNL.0000000000004021. No abstract available.
  4. Total cerebral small vessel disease score and cognitive performance in community-dwelling older adults. Results from the Atahualpa Project. Del Brutto VJ, Ortiz JG, Del Brutto OH, Mera RM, Zambrano M, Biller J. Int J Geriatr Psychiatry. 2017 May 26. doi: 10.1002/gps.4747. [Epub ahead of print]
  5. Inverse relationship between the body mass index and severity of carotid siphon calcifications (another obesity paradox): Results from the Atahualpa Project. Del Brutto OH, Mera RM; Atahualpa Project Investigators. Atherosclerosis. 2017 Apr;259:1-4. doi: 10.1016/j.atherosclerosis.2017.02.023. Epub 2017 Feb 27.
  6. The association between poor sleep quality and global cortical atrophy is related to age. Results from the Atahualpa Project. Del Brutto OH, Mera RM, Zambrano M, Castillo PR. Sleep Sci. 2016 Jul-Sep;9(3):147-150. doi: 10.1016/j.slsci.2016.06.004. Epub 2016 Sep 9.
  7. Declining incidence of intracerebral hemorrhage. Del Brutto OH. Eur J Neurol. 2017 Feb;24(2):e10. doi: 10.1111/ene.13221. No abstract available.
  8. The Association Between Neurocysticercosis and Hippocampal Atrophy is Related to Age. Del Brutto OH, Issa NP, Salgado P, Del Brutto VJ, Zambrano M, Lama J, García HH. Am J Trop Med Hyg. 2017 Jan 11;96(1):243-248. doi: 10.4269/ajtmh.16-0689. Epub 2016 Nov 14.
  9. Poor reliability of sleep questionnaires for the detection of sleep disordered breathing in a rural setting (The Atahualpa Project). Del Brutto OH, Zambrano M, Castillo PR. Sleep Med. 2017 Apr;32:272. doi: 10.1016/j.sleep.2016.09.023. Epub 2016 Nov 17. No abstract available.
  10. Revised diagnostic criteria for neurocysticercosis. Del Brutto OH, Nash TE, White AC Jr, Rajshekhar V, Wilkins PP, Singh G, Vasquez CM, Salgado P, Gilman RH, Garcia HH. J Neurol Sci. 2017 Jan 15;372:202-210. doi: 10.1016/j.jns.2016.11.045. Epub 2016 Nov 21. Review.
  11. Revised set of diagnostic criteria for neurocysticercosis (in reply to Garg and Malhotra). Del Brutto OH, Nash TE, White AC Jr, Rajshekhar V, Wilkins PP, Singh G, Vasquez CM, Salgado P, Gilman RH, Garcia HH. J Neurol Sci. 2017 Feb 15;373:350-351. doi: 10.1016/j.jns.2016.12.018. Epub 2016 Dec 14. No abstract available.
  12. Severe edentulism is a major risk factor influencing stroke incidence in rural Ecuador (The Atahualpa Project). Del Brutto OH, Mera RM, Zambrano M, Del Brutto VJ. Int J Stroke. 2017 Feb;12(2):201-204. doi: 10.1177/1747493016676621. Epub 2016 Oct 24.
  13. The importance of people compliance (social desirability bias) in the assessment of epilepsy prevalence in rural areas of developing countries. Results of the Atahualpa Project. Del Brutto OH, Mera RM; Atahualpa Project Investigators. Epilepsia. 2016 Dec;57(12):e221-e224. doi: 10.1111/epi.13594. Epub 2016 Oct 24.
  14. The Influence of Age in the Relationship between Cerebral Small Vessel Disease and Edentulism. The Atahualpa Project. Del Brutto OH, Mera RM, Zambrano M. Eur Neurol. 2016;76(3-4):112-116. Epub 2016 Aug 17.
  15. Diagnostic criteria for neurocysticercosis. Del Brutto OH. Ann Neurol. 2016 Dec;80(6):953-954. doi: 10.1002/ana.24795. Epub 2016 Nov 12. No abstract available.
  16. The burden of diabetes-related foot disorders in community-dwellers living in rural Ecuador: Results of the Atahualpa Project. Del Brutto OH, Mera RM, King NR, Zambrano M, Sullivan LJ. Foot (Edinb). 2016 Aug;28:26-29. doi: 10.1016/j.foot.2016.05.003. Epub 2016 Jun 2.
  17. Years of Drinking but Not the Amount of Alcohol Intake Contribute to the Association Between Alcoholic Cerebellar Degeneration and Worse Cognitive Performance. A Population-Based Study. Del Brutto OH, Mera RM, King NR, Zambrano M, Sullivan LJ. Cerebellum. 2017 Apr;16(2):612-614. doi: 10.1007/s12311-016-0824-7. No abstract available.
  18. Ankle-brachial index determination for assessment of intracranial atherosclerosis. Del Brutto OH, Mera RM, King NR, Sullivan LJ, Zambrano M. Int J Cardiol. 2016 Nov 1;222:701-2. doi: 10.1016/j.ijcard.2016.08.073. Epub 2016 Aug 4. No abstract available.
  19. Population-based study of alcoholic cerebellar degeneration: The Atahualpa Project. Del Brutto OH, Mera RM, Sullivan LJ, Zambrano M, King NR. J Neurol Sci. 2016 Aug 15;367:356-60. doi: 10.1016/j.jns.2016.06.051. Epub 2016 Jun 24.
  20. Calcifications in the carotid siphon inversely associate with cognitive performance in stroke-free community dwellers living in rural Ecuador (The Atahualpa Project). Del Brutto OH, Mera RM, Sullivan LJ, Zambrano M, King NR. Int J Stroke. 2016 Oct;11(8):935-937. doi: 10.1177/1747493016660105. Epub 2016 Jul 11.
  21. Hypertensive retinopathy and cerebral small vessel disease in Amerindians living in rural Ecuador: The Atahualpa Project. Del Brutto OH, Mera RM, Viteri EM, Pólit J, Ledesma EA, Cano JA, Plaza KJ, Zambrano M, Costa AF. Int J Cardiol. 2016 Sep 1;218:65-8. doi: 10.1016/j.ijcard.2016.05.020. Epub 2016 May 13.
  22. Antiepileptic drug therapy and recommendations for withdrawal in patients with seizures and epilepsy due to neurocysticercosis. Bustos JA, García HH, Del Brutto OH. Expert Rev Neurother. 2016 Sep;16(9):1079-85. doi: 10.1080/14737175.2016.1194757. Epub 2016 Jun 8. Review.
  23. Caffeine intake has no effect on sleep quality in community dwellers living in a rural Ecuadorian village (The Atahualpa Project). Del Brutto OH, Mera RM, Zambrano M, Castillo PR. Sleep Sci. 2016 Jan-Mar;9(1):35-9. doi: 10.1016/j.slsci.2015.12.003. Epub 2016 Jan 4.
  24. Presence of Cerebral Microbleeds Is Unrelated to the Body Mass Index in Amerindians. A Population Study in Rural Ecuador (The Atahualpa Project). Del Brutto OH, Mera RM, Zambrano M, Feraud S. Eur Neurol. 2016;75(3-4):164-8. doi: 10.1159/000445052. Epub 2016 Mar 19.
  25. Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study. Boehme AK, McClure LA, Zhang Y, Luna JM, Del Brutto OH, Benavente OR, Elkind MS. Stroke. 2016 Mar;47(3):659-67. doi: 10.1161/STROKEAHA.115.012166.
  26. Dietary fish intake and sleep quality: a population-based study. Del Brutto OH, Mera RM, Ha JE, Gillman J, Zambrano M, Castillo PR. Sleep Med. 2016 Jan;17:126-8. doi: 10.1016/j.sleep.2015.09.021. Epub 2015 Nov 6.
  27. The bicaudate index inversely associates with performance in the Montreal Cognitive Assessment (MoCA) in older adults living in rural Ecuador. The Atahualpa project. Del Brutto OH, Mera RM, Del Brutto VJ, Sedler MJ. Int J Geriatr Psychiatry. 2016 Aug;31(8):944-50. doi: 10.1002/gps.4419. Epub 2016 Feb 2.
  28. The Effect of Age in the Association between Frailty and Poor Sleep Quality: A Population-Based Study in Community-Dwellers (The Atahualpa Project). Del Brutto OH, Mera RM, Sedler MJ, Zambrano M, Nieves JL, Cagino K, Fanning KD, Milla-Martinez MF, Castillo PR. J Am Med Dir Assoc. 2016 Mar 1;17(3):269-71. doi: 10.1016/j.jamda.2015.12.009. Epub 2016 Jan 28.
  29. Neuroimaging signatures of frailty: A population-based study in community-dwelling older adults (the Atahualpa Project). Del Brutto OH, Mera RM, Cagino K, Fanning KD, Milla-Martinez MF, Nieves JL, Zambrano M, Sedler MJ. Geriatr Gerontol Int. 2017 Feb;17(2):270-276. doi: 10.1111/ggi.12708. Epub 2016 Jan 21.
  30. Update on Cysticercosis Epileptogenesis: the Role of the Hippocampus. Del Brutto OH, Engel J Jr, Eliashiv DS, García HH. Curr Neurol Neurosci Rep. 2016 Jan;16(1):1. doi: 10.1007/s11910-015-0601-x. Review.
  31. Willis-Ekbom disease is not associated with poor cardiovascular health in adults. Dredla BK, Del Brutto OH, Lee AS, Castillo PR. J Negat Results Biomed. 2015 Nov 6;14:17. doi: 10.1186/s12952-015-0038-4.
  32. Oily fish consumption is inversely correlated with cerebral microbleeds in community-dwelling older adults: results from the Atahualpa Project. Del Brutto OH, Mera RM, Ha JE, Del Brutto VJ, Castillo PR, Zambrano M, Gillman J. Aging Clin Exp Res. 2016 Aug;28(4):737-43. doi: 10.1007/s40520-015-0473-6. Epub 2015 Oct 26.
  33. Excessive daytime somnolence and cardiovascular health: A population-based study in rural Ecuador. Del Brutto OH, Mera RM, Zambrano M, Castillo PR. Sleep Sci. 2014 Dec;7(4):186-8. doi: 10.1016/j.slsci.2014.10.001. Epub 2014 Oct 16.
  34. The association of frailty with abnormal ankle-brachial index determinations is related to age: Results from the Atahualpa Project. Del Brutto OH, Mera RM, Brown DL, Nieves JL, Milla-Martinez MF, Fanning KD, Cagino K, Zambrano M, Sedler MJ. Int J Cardiol. 2016 Jan 1;202:366-7. doi: 10.1016/j.ijcard.2015.09.039. Epub 2015 Sep 21. No abstract available.
  35. The association of sleep-disordered breathing with high cerebral pulsatility might not be related to diffuse small vessel disease. A pilot study. Castillo PR, Del Brutto OH, Andrade Mde L, Zambrano M, Nader JA. BMC Res Notes. 2015 Sep 29;8:500. doi: 10.1186/s13104-015-1481-5.
  36. Dietary Oily Fish Intake and Blood Pressure Levels: A Population-Based Study. Del Brutto OH, Mera RM, Gillman J, Castillo PR, Zambrano M, Ha JE. J Clin Hypertens (Greenwich). 2016 Apr;18(4):337-41. doi: 10.1111/jch.12684. Epub 2015 Sep 23.
  37. Calcifications in the carotid siphon correlate with silent cerebral small vessel disease in community-dwelling older adults: A population-based study in rural Ecuador. Del Brutto OH, Mera RM, Gillman J, Ha JE, Zambrano M. Geriatr Gerontol Int. 2016 Sep;16(9):1063-7. doi: 10.1111/ggi.12599. Epub 2015 Sep 3.
  38. Taenia solium Cysticercosis–The lessons of history. Del Brutto OH, García HH. J Neurol Sci. 2015 Dec 15;359(1-2):392-5. doi: 10.1016/j.jns.2015.08.011. Epub 2015 Aug 7. Review.
  39. Intracranial arterial stenosis in Ecuadorian Natives/Mestizos. A population-based study in older adults (The Atahualpa Project). Del Brutto OH, Mera RM, Lama J, Zambrano M, Del Brutto VJ. Arch Gerontol Geriatr. 2015 Nov-Dec;61(3):480-3. doi: 10.1016/j.archger.2015.08.011. Epub 2015 Aug 11.
  40. Cerebrovascular correlates of vitamin D deficiency in older adults living near the Equator: results from the Atahualpa Project. Del Brutto OH, Mera RM, Macias J, Morales G, Zambrano M. Int J Stroke. 2015 Dec;10(8):1301-3. doi: 10.1111/ijs.12627. Epub 2015 Aug 26.
  41. Oily Fish Intake and Cognitive Performance in Community-Dwelling Older Adults: The Atahualpa Project. Del Brutto OH, Mera RM, Gillman J, Zambrano M, Ha JE. J Community Health. 2016 Feb;41(1):82-6. doi: 10.1007/s10900-015-0070-9.
  42. Temporal bone thickness and texture are major determinants of the high rate of insonation failures of transcranial Doppler in Amerindians (the Atahualpa Project). Del Brutto OH, Mera RM, de la Luz Andrade M, Espinosa V, Castillo PR, Zambrano M, Nader JA. J Clin Ultrasound. 2016 Jan;44(1):55-60. doi: 10.1002/jcu.22284. Epub 2015 Jul 14.
  43. Disappointing reliability of pulsatility indices to identify candidates for magnetic resonance imaging screening in population-based studies assessing prevalence of cerebral small vessel disease. Del Brutto OH, Mera RM, Andrade Mde L, Castillo PR, Zambrano M, Nader JA. J Neurosci Rural Pract. 2015 Jul-Sep;6(3):336-8. doi: 10.4103/0976-3147.158760.
  44. Metabolic syndrome correlates poorly with cognitive performance in stroke-free community-dwelling older adults: a population-based, cross-sectional study in rural Ecuador. Del Brutto OH, Mera RM, Zambrano M. Aging Clin Exp Res. 2016 Apr;28(2):321-5. doi: 10.1007/s40520-015-0404-6. Epub 2015 Jul 5.
  45. In response: Multifactorial basis of epilepsy in patients with neurocysticercosis. Nash TE, Mahanty S, Loeb JA, Theodore WH, Friedman A, Sander JW, Singh G, Cavalheiro E, Del Brutto OH, Takayanagui OM, Fleury A, Verastegui M, Preux PM, Montano S, Pretell EJ, White AC Jr, Gonzales AE, Gilman RH, Garcia HH. Epilepsia. 2015 Jun;56(6):975-6. doi: 10.1111/epi.12986. No abstract available.
  46. Population-Based Study of Cerebral Microbleeds in Stroke-Free Older Adults Living in Rural Ecuador: The Atahualpa Project. Del Brutto VJ, Zambrano M, Mera RM, Del Brutto OH. Stroke. 2015 Jul;46(7):1984-6. doi: 10.1161/STROKEAHA.115.009594. Epub 2015 May 28.
  47. The Relationship Between High Pulse Pressure and Low Ankle-Brachial Index. Potential Utility in Screening for Peripheral Artery Disease in Population-Based Studies. Del Brutto OH, Mera RM, Sedler MJ, Gruen JA, Phelan KJ, Cusick EH, Zambrano M, Brown DL. High Blood Press Cardiovasc Prev. 2015 Sep;22(3):275-80. doi: 10.1007/s40292-015-0103-6. Epub 2015 May 19.
  48. Technical difficulties due to poor acoustic insonation during transcranial Doppler recordings in Amerindians and individuals of European origin. A comparative study. Nader JA, Andrade Mde L, Espinosa V, Zambrano M, Del Brutto OH. Eur Neurol. 2015;73(3-4):230-2. doi: 10.1159/000380819. Epub 2015 Mar 14.
  49. Intrathecal gadodiamide for identifying subarachnoid and ventricular neurocysticercosis. Higuera-Calleja J, Góngora-Rivera F, Soto-Hernández JL, Del-Brutto OH, Moreno-Andrade T, Gutiérrez-Alvarado R, Rodríguez-Carbajal J. Trop Med Int Health. 2015 Jul;20(7):930-3. doi: 10.1111/tmi.12495. Epub 2015 Mar 17.
  50. Cognitive performance in community-dwelling older adults with stroke and the contribution of age and diffuse subcortical damage: a population-based study in rural Ecuador (The Atahualpa Project). Del Brutto OH, Mera RM, Zambrano M, Lama J. Aging Clin Exp Res. 2015 Oct;27(5):647-52. doi: 10.1007/s40520-015-0331-6. Epub 2015 Feb 28.
  51. Poor sleep quality and silent markers of cerebral small vessel disease: a population-based study in community-dwelling older adults (The Atahualpa Project). Del Brutto OH, Mera RM, Zambrano M, Lama J, Del Brutto VJ, Castillo PR. Sleep Med. 2015 Mar;16(3):428-31. doi: 10.1016/j.sleep.2014.10.023. Epub 2015 Jan 28.
  52. The neglected strokes–cerebrovascular complications of neglected tropical diseases. Del Brutto OH. Int J Stroke. 2015 Feb;10(2):E14-5. doi: 10.1111/ijs.12414. No abstract available.
  53. Stroke and pineal gland calcification: lack of association. Results from a population-based study (The Atahualpa Project). Del Brutto OH, Mera RM, Lama J, Zambrano M. Clin Neurol Neurosurg. 2015 Mar;130:91-4. doi: 10.1016/j.clineuro.2014.12.019. Epub 2015 Jan 5.
  54. Animal naming in the Spanish version of the Montreal Cognitive Assessment in rural Latin American communities: a cautionary note. Del Brutto OH, Wright C. Geriatr Gerontol Int. 2015 Jan;15(1):126-7. doi: 10.1111/ggi.12223. No abstract available.
  55. The association of ankle-brachial index with silent cerebral small vessel disease: results of the Atahualpa Project. Del Brutto OH, Sedler MJ, Mera RM, Lama J, Gruen JA, Phelan KJ, Cusick EH, Zambrano M, Brown DL. Int J Stroke. 2015 Jun;10(4):589-93. doi: 10.1111/ijs.12450. Epub 2015 Jan 12.
  56. Hippocampal sclerosis: the missing link of cysticercosis epileptogenesis? Del Brutto OH, Engel J Jr, Eliashiv DS, Salamon N, García HH. Epilepsia. 2014 Dec;55(12):2077-8. doi: 10.1111/epi.12899. No abstract available.
  57. Neurocysticercosis: A natural human model of epileptogenesis. Nash TE, Mahanty S, Loeb JA, Theodore WH, Friedman A, Sander JW, Singh G, Cavalheiro E, Del Brutto OH, Takayanagui OM, Fleury A, Verastegui M, Preux PM, Montano S, Pretell EJ, White AC Jr, Gonzales AE, Gilman RH, Garcia HH. Epilepsia. 2015 Feb;56(2):177-83. doi: 10.1111/epi.12849. Epub 2014 Dec 23. Review.
  58. Psychological distress in patients with restless legs syndrome (Willis-Ekbom disease): a population-based door-to-door survey in rural Ecuador. Castillo PR, Mera RM, Fredrickson PA, Zambrano M, Del Brutto VJ, Del Brutto OH. BMC Res Notes. 2014 Dec 15;7:911. doi: 10.1186/1756-0500-7-911.
  59. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Garcia HH, Nash TE, Del Brutto OH. Lancet Neurol. 2014 Dec;13(12):1202-15. doi: 10.1016/S1474-4422(14)70094-8. Epub 2014 Nov 10. Review.
  60. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Pearce LA, McClure LA, Anderson DC, Jacova C, Sharma M, Hart RG, Benavente OR; SPS3 Investigators. Lancet Neurol. 2014 Dec;13(12):1177-85. doi: 10.1016/S1474-4422(14)70224-8. Epub 2014 Oct 23.
  61. The tapeworm that turned. Garcia HH, Nash TE, Del Brutto OH. Lancet Neurol. 2014 Dec;13(12):1173. doi: 10.1016/S1474-4422(14)70275-3. Epub 2014 Nov 10. No abstract available.
  62. Comparison of field questionnaires with the ankle-brachial index for the detection of peripheral artery disease. A population-based study in rural Ecuador. Del Brutto OH, Sedler MJ, Zambrano M, Mera RM, Phelan KJ, Gruen JA, Cusick EH, Moral CF, Del Brutto VJ, Castillo PR, Brown DL. Int J Cardiol. 2014 Dec 15;177(2):703-4. doi: 10.1016/j.ijcard.2014.09.188. Epub 2014 Oct 5. No abstract available.
  63. Incompleteness of the Circle of Willis correlates poorly with imaging evidence of small vessel disease. A population-based study in rural Ecuador (the Atahualpa project). Del Brutto OH, Mera RM, Zambrano M, Lama J. J Stroke Cerebrovasc Dis. 2015 Jan;24(1):73-7. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.036. Epub 2014 Oct 16.
  64. White matter hyperintensities of presumed vascular origin: a population-based study in rural Ecuador (The Atahualpa Project). Del Brutto OH, Mera RM, Del Brutto VJ, Zambrano M, Lama J. Int J Stroke. 2015 Apr;10(3):372-5. doi: 10.1111/ijs.12417. Epub 2014 Dec 1.
  65. Prevalence, correlates, and prognosis of peripheral artery disease in rural ecuador-rationale, protocol, and phase I results of a population-based survey: an atahualpa project-ancillary study. Del Brutto OH, Sedler MJ, Mera RM, Castillo PR, Cusick EH, Gruen JA, Phelan KJ, Del Brutto VJ, Zambrano M, Brown DL. Int J Vasc Med. 2014;2014:643589. doi: 10.1155/2014/643589. Epub 2014 Sep 21.
  66. Neurocysticercosis. Del Brutto OH. Neurohospitalist. 2014 Oct;4(4):205-12. doi: 10.1177/1941874414533351.
  67. Calcified neurocysticercosis associates with hippocampal atrophy: a population-based study. Del Brutto OH, Salgado P, Lama J, Del Brutto VJ, Campos X, Zambrano M, García HH. Am J Trop Med Hyg. 2015 Jan;92(1):64-8. doi: 10.4269/ajtmh.14-0453. Epub 2014 Oct 27.
  68. Neurocysticercosis is a neglected microbleed mimic. a cautionary note for stroke neurologists. Del Brutto OH, Lama J, Zambrano M, Del Brutto VJ. Eur Neurol. 2014;72(5-6):306-8. doi: 10.1159/000365847. Epub 2014 Oct 14.
  69. Global cortical atrophy (GCA) associates with worse performance in the Montreal Cognitive Assessment (MoCA). A population-based study in community-dwelling elders living in rural Ecuador. Del Brutto OH, Mera RM, Zambrano M, Soriano F, Lama J. Arch Gerontol Geriatr. 2015 Jan-Feb;60(1):206-9. doi: 10.1016/j.archger.2014.09.010. Epub 2014 Sep 26.
  70. Pineal gland calcification is not associated with sleep-related symptoms. A population-based study in community-dwelling elders living in Atahualpa (rural coastal Ecuador). Del Brutto OH, Mera RM, Lama J, Zambrano M, Castillo PR. Sleep Med. 2014 Nov;15(11):1426-7. doi: 10.1016/j.sleep.2014.07.008. Epub 2014 Sep 1. No abstract available.
  71. Influence of depression, anxiety and stress on cognitive performance in community-dwelling older adults living in rural Ecuador: results of the Atahualpa Project.
  72. Del Brutto OH, Mera RM, Del Brutto VJ, Maestre GE, Gardener H, Zambrano M, Wright CB. Geriatr Gerontol Int. 2015 Apr;15(4):508-14. doi: 10.1111/ggi.12305. Epub 2014 Aug 26.
  73. Edentulism associates with poor cardiovascular health. Results from the Atahualpa Project. Del Brutto OH, Mera RM, Del Brutto VJ, Zambrano M, Montenegro JE, Castillo PR. Int J Cardiol. 2014 Oct 20;176(3):1013-4. doi: 10.1016/j.ijcard.2014.07.083. Epub 2014 Aug 1. No abstract available.
  74. Prevalence of Willis-Ekbom disease in rural coastal Ecuador. A two-phase, door-to-door, population-based survey. Del Brutto OH, Del Brutto VJ, Zambrano M, Castillo PR. J Neurol Sci. 2014 Sep 15;344(1-2):139-42. doi: 10.1016/j.jns.2014.06.043. Epub 2014 Jun 28.
  75. Population-based study of facial morphology and excessive daytime somnolence. Castillo PR, Mera RM, Zambrano M, Del Brutto OH. Pathophysiology. 2014 Nov;21(4):289-92. doi: 10.1016/j.pathophys.2014.06.001. Epub 2014 Jun 13.
  76. Sleep-related symptoms in Ecuadorian natives/mestizos with and without stroke: an Atahualpa Project case-control nested study. Del Brutto OH, Zambrano M, Castillo PR. Int J Stroke. 2014 Jul;9(5):E21. doi: 10.1111/ijs.12286. No abstract available.
  77. Indices of abdominal obesity may be better than the BMI to discriminate Latin American natives/mestizos with a poor cardiovascular status. Del Brutto OH, Mera RM; Atahualpa Project Investigators. Diabetes Metab Syndr. 2014 Apr-Jun;8(2):115-8. doi: 10.1016/j.dsx.2014.04.002. Epub 2014 May 22.
  78. Variants in the circle of Willis and white matter disease in Ecuadorian Mestizos. Del Brutto OH, Lama J. J Neuroimaging. 2015 Jan-Feb;25(1):124-6. doi: 10.1111/jon.12077. Epub 2014 Feb 19.
  79. Edentulism associates with worse cognitive performance in community-dwelling elders in rural Ecuador: results of the Atahualpa project. Del Brutto OH, Gardener H, Del Brutto VJ, Maestre GE, Zambrano M, Montenegro JE, Wright CB. J Community Health. 2014 Dec;39(6):1097-100. doi: 10.1007/s10900-014-9857-3.
  80. Clinical management of neurocysticercosis. Del Brutto OH. Expert Rev Neurother. 2014 Apr;14(4):389-96. doi: 10.1586/14737175.2014.890892. Epub 2014 Feb 19. Review.
  81. Low prevalence of ischemic heart disease in rural coastal Ecuador: an issue of high mortality rate? Peñaherrera E, Pow-Chon-Long F, Del Brutto OH. Rural Remote Health. 2014;14:2623. Epub 2014 Feb 16. No abstract available.
  82. C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study. Elkind MS, Luna JM, McClure LA, Zhang Y, Coffey CS, Roldan A, Del Brutto OH, Pretell EJ, Pettigrew LC, Meyer BC, Tapia J, White C, Benavente OR; LIMITS Investigators. Stroke. 2014 Mar;45(3):707-16. doi: 10.1161/STROKEAHA.113.004562. Epub 2014 Feb 12.
  83. Association between sleep quality and cardiovascular health: a door-to-door survey in rural Ecuador. Del Brutto OH, Mera RM, Zambrano M, Del Brutto VJ, Castillo PR. Environ Health Prev Med. 2014 May;19(3):234-7. doi: 10.1007/s12199-014-0379-5. Epub 2014 Jan 30.
  84. Human cysticercosis (Taenia solium). Del Brutto OH. Trop Parasitol. 2013 Jul;3(2):100-3. doi: 10.4103/2229-5070.122103. No abstract available.
  85. Cardiovascular health and caffeine consumption. A population-based study in rural Ecuador. Del Brutto OH, Mera RM, Zambrano M. Int J Cardiol. 2014 Mar 1;172(1):284-5. doi: 10.1016/j.ijcard.2013.12.237. Epub 2014 Jan 10. No abstract available.
  86. Neurocysticercosis in a European traveler returning from India, primarily suspected as neoplasia. Del Brutto OH. J Travel Med. 2014 Jan-Feb;21(1):75. doi: 10.1111/jtm.12078_1. No abstract available.
  87. Neurocysticercosis. Del Brutto OH. Handb Clin Neurol. 2014;121:1445-59. doi: 10.1016/B978-0-7020-4088-7.00097-3. Review.
  88. Prevalence of the metabolic syndrome and its correlation with the cardiovascular health status in stroke- and ischemic heart disease-free Ecuadorian natives/mestizos aged ≥40 years living in Atahualpa: a population-based study. Del Brutto OH, Zambrano M, Peñaherrera E, Montalván M, Pow-Chon-Long F, Tettamanti D. Diabetes Metab Syndr. 2013 Oct-Dec;7(4):218-22. doi: 10.1016/j.dsx.2013.10.006. Epub 2013 Nov 13.
  89. Implications and expectancies of the “Atahualpa Project”: A population-based survey designed to reduce the burden of stroke and cardiovascular diseases in rural Ecuador. Del Brutto OH. J Neurosci Rural Pract. 2013 Jul;4(3):363-5. doi: 10.4103/0976-3147.118776. No abstract available.
  90. Movement Disorders Among Adult Neurological Outpatients Evaluated over 20 Years in Guayaquil, Ecuador. Del Brutto OH, Del Brutto VJ. Neurol Int. 2013 Aug 20;5(3):e18. doi: 10.4081/ni.2013.e18. eCollection 2013.
  91. Cerebrovascular correlates of sleep disorders-rational and protocol of a door-to-door survey in rural Coastal Ecuador. Del Brutto OH, Mera RM, Farfán R, Castillo PR; Atahualpa Project Investigators. J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1030-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.020. Epub 2013 Oct 6.
  92. Stroke in rural coastal Ecuador: a community-based survey. Del Brutto OH, Santamaría M, Zambrano M, Peñaherrera E, Pow-Chon-Long F, Del Brutto VJ, Ochoa E, Valdiviezo E, Santibáñez R. Int J Stroke. 2014 Apr;9(3):365-6. doi: 10.1111/ijs.12102. Epub 2013 Aug 26.
  93. Reversible posterior leukoencephalopathy after venomous bites and stings. Del Brutto OH.
  94. Neurotoxicology. 2013 Dec;39:10. doi: 10.1016/j.neuro.2013.07.008. Epub 2013 Aug 7. No abstract available.
  95. The importance of neurocysticercosis in stroke in rural areas of a developing Latin American country. Del Brutto OH, Lama J; Atahualpa Project Investigators. Am J Trop Med Hyg. 2013 Aug;89(2):374-5. doi: 10.4269/ajtmh.13-0196. Epub 2013 Jul 8.
  96. Cardiovascular health status and metabolic syndrome in Ecuadorian natives/Mestizos aged 40 years or more with and without stroke and ischemic heart disease–an atahualpa project case-control nested study. Del Brutto OH, Mera RM, Montalván M, Del Brutto VJ, Zambrano M, Santamaría M, Tettamanti D. J Stroke Cerebrovasc Dis. 2014 Apr;23(4):643-8. doi: 10.1016/j.jstrokecerebrovasdis.2013.06.001. Epub 2013 Jul 5.
  97. Sawdust in carpentry workshops in rural areas of developing countries. Del Brutto OH, Reich A, Zambrano M. J Epidemiol Community Health. 2013 Nov 1;67(11):973. doi: 10.1136/jech-2013-202970. Epub 2013 Jul 6. No abstract available.
  98. Neurological effects of venomous bites and stings: snakes, spiders, and scorpions. Del Brutto OH. Handb Clin Neurol. 2013;114:349-68. doi: 10.1016/B978-0-444-53490-3.00028-5. Review.
  99. Neurocysticercosis. Del Brutto OH, Garcia HH. Handb Clin Neurol. 2013;114:313-25. doi: 10.1016/B978-0-444-53490-3.00025-X. Review.
  100. Intramedullary cysticercosis of the spinal cord: a review of patients evaluated with MRI. Del Brutto OH, Garcia HH. J Neurol Sci. 2013 Aug 15;331(1-2):114-7. doi: 10.1016/j.jns.2013.05.025. Epub 2013 Jun 6. Review.
  101. Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. White CL, Pergola PE, Szychowski JM, Talbert R, Cervantes-Arriaga A, Clark HD, Del Brutto OH, Godoy IE, Hill MD, Pelegrí A, Sussman CR, Taylor AA, Valdivia J, Anderson DC, Conwit R, Benavente OR; SPS3 Investigators.Am J Hypertens. 2013 Sep;26(9):1114-22. doi: 10.1093/ajh/hpt076. Epub 2013 Jun 4.
  102. Living alone and cardiovascular health status in residents of a rural village of coastal Ecuador (The Atahualpa Project). Del Brutto OH, Tettamanti D, Del Brutto VJ, Zambrano M, Montalván M. Environ Health Prev Med. 2013 Sep;18(5):422-5. doi: 10.1007/s12199-013-0344-8. Epub 2013 Jun 4.
  103. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. SPS3 Study Group, Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, Pearce LA, Pergola PE, Szychowski JM. Lancet. 2013 Aug 10;382(9891):507-15. doi: 10.1016/S0140-6736(13)60852-1. Epub 2013 May 29. Erratum in: Lancet. 2013 Aug 10;382(9891):506. Coffey, C S [aded].
  104. Scorpion stings: focus on cerebrovascular complications of envenoming. Del Brutto OH, Del Brutto VJ. Int J Stroke. 2013 Jun;8(4):E8. doi: 10.1111/j.1747-4949.2012.00940.x. No abstract available.
  105. The Iberoamerican Cerebrovascular Diseases Society: 15 years moving forward. Del Brutto OH, Diez-Tejedor E, Sacks C, Ameriso SF, Náder J, Alonso de Leciñana M, Massaro A. Int J Stroke. 2013 Jun;8(4):276-7. doi: 10.1111/ijs.12058.
  106. Neurocysticercosis in infants and toddlers: report of seven cases and review of published patients. Del Brutto OH. Pediatr Neurol. 2013 Jun;48(6):432-5. doi: 10.1016/j.pediatrneurol.2013.02.001. Review.
  107. The “know your numbers” program in Atahualpa–a pilot study aimed to reduce cardiovascular diseases and stroke burden in rural communities of developing countries. Del Brutto OH, Montalván M, Tettamanti D, Peñaherrera E, Santibáñez R, Pow-Chon-Long F, Del Brutto VJ. Int J Cardiol. 2013 Oct 3;168(3):3123-4. doi: 10.1016/j.ijcard.2013.04.049. Epub 2013 May 4. No abstract available.
  108. Intrasellar cysticercosis: a systematic review. Del Brutto OH, Del Brutto VJ. Acta Neurol Belg. 2013 Sep;113(3):225-7. doi: 10.1007/s13760-013-0199-1. Epub 2013 Apr 20. Review.
  109. Door-to-door survey of cardiovascular health, stroke, and ischemic heart disease in rural coastal Ecuador–the Atahualpa Project: methodology and operational definitions. Del Brutto OH, Peñaherrera E, Ochoa E, Santamaría M, Zambrano M, Del Brutto VJ; Atahualpa Project Investigators. Int J Stroke. 2014 Apr;9(3):367-71. doi: 10.1111/ijs.12030. Epub 2013 Mar 19.
  110. Is the rate of cerebral hemorrhages declining among stroke patients in South America? Del Brutto OH, Del Brutto VJ. Int J Stroke. 2014 Feb;9(2):207-9. doi: 10.1111/ijs.12031. Epub 2013 Mar 19.
  111. Neurocysticercosis: new thoughts on controversial issues. Del Brutto OH. Curr Opin Neurol. 2013 Jun;26(3):289-94. doi: 10.1097/WCO.0b013e32836027fa. Review.
  112. Cardiovascular health status among Caribbean Hispanics living in Northern Manhattan and Ecuadorian natives/mestizos in rural coastal Ecuador: a comparative study. Del Brutto OH, Dong C, Rundek T, Elkind MS, Del Brutto VJ, Sacco RL. J Community Health. 2013 Aug;38(4):634-41. doi: 10.1007/s10900-013-9658-0.
  113. Population-based study of cardiovascular health in Atahualpa, a rural village of coastal Ecuador. Del Brutto OH, Santamaría M, Ochoa E, Peñaherrera E, Santibáñez R, Pow-Chon-Long F, Zambrano M, Del Brutto VJ. Int J Cardiol. 2013 Sep 30;168(2):1618-20. doi: 10.1016/j.ijcard.2013.01.017. Epub 2013 Feb 11. No abstract available.
  114. Prevalence of Parkinson’s disease in a rural village of coastal Ecuador. A two-phase door-to-door survey. Del Brutto OH, Santibáñez R, Santamaría M. Acta Neurol Belg. 2013 Sep;113(3):253-6. doi: 10.1007/s13760-013-0181-y. Epub 2013 Jan 29.
  115. Isolated brainstem cysticercosis: a review. Del Brutto OH, Del Brutto VJ. Clin Neurol Neurosurg. 2013 May;115(5):507-11. doi: 10.1016/j.clineuro.2012.12.026. Epub 2013 Jan 22. Review.
  116. Neurocysticercosis: declining incidence among patients admitted to a large public hospital in Guayaquil, Ecuador. Alarcón TA, Del Brutto OH. Pathog Glob Health. 2012 Sep;106(5):310-1. doi: 10.1179/2047773212Y.0000000044.
  117. Diagnostic criteria for neurocysticercosis, revisited. Del Brutto OH. Pathog Glob Health. 2012 Sep;106(5):299-304. doi: 10.1179/2047773212Y.0000000025. Review.
  118. Taenia solium cysticercosis: new challenges for an old scourge. Del Brutto OH, García HH. Pathog Glob Health. 2012 Sep;106(5):253. doi: 10.1179/2047772412Z.00000000071. No abstract available.
  119. Neurocysticercosis on the Arabian Peninsula, 2003-2011. Del Brutto OH. Emerg Infect Dis. 2013 Jan;19(1):172-4. doi: 10.3201/eid1901.120432. No abstract available.
  120. Neurocysticercosis. Del Brutto OH. Continuum (Minneap Minn). 2012 Dec;18(6 Infectious Disease):1392-416. doi: 10.1212/01.CON.0000423853.47770.90. Review.
  121. Changing profile of 7,519 neurologic outpatients evaluated over 20 years. Del Brutto VJ, Tettamanti D, Del Brutto OH. Eur Neurol. 2012;68(6):381-90. doi: 10.1159/000341344. Epub 2012 Oct 27.
  122. Single parenchymal brain cysticercus: relationship between age of patients and evolutive stage of parasites. Del Brutto VJ, Del Brutto OH, Ochoa E, García HH. Neurol Res. 2012 Dec;34(10):967-70. doi: 10.1179/1743132812Y.0000000100. Epub 2012 Oct 11.
  123. Teaching neuroimages: Gradenigo syndrome. Delgado ME, Del Brutto OH. Neurology. 2012 Oct 16;79(16):e141. doi: 10.1212/WNL.0b013e31826e9b89. No abstract available.
  124. Massive neurocysticercosis: encephalitic versus non-encephalitic. Del Brutto OH, Campos X. Am J Trop Med Hyg. 2012 Sep;87(3):381. doi: 10.4269/ajtmh.2012.12-0162. No abstract available.
  125. Neurocysticercosis in a 2-year-old boy infected at home. Del Brutto OH. Pathog Glob Health. 2012 May;106(2):122-3. doi: 10.1179/2047773212Y.0000000009.
  126. Infection and inflammation. Garcia HH, Del Brutto OH. Handb Clin Neurol. 2012;108:601-20. doi: 10.1016/B978-0-444-52899-5.00018-6. Review. No abstract available.
  127. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. SPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA. N Engl J Med. 2012 Aug 30;367(9):817-25. doi: 10.1056/NEJMoa1204133.
  128. Neurocysticercosis in nonendemic countries: time for a reappraisal. Del Brutto OH, García HH. Neuroepidemiology. 2012;39(2):145-6. Epub 2012 Aug 22. No abstract available.
  129. Cysticerci-related single parenchymal brain enhancing lesions in non-endemic countries. Del Brutto OH, Nash TE, Garcia HH. J Neurol Sci. 2012 Aug 15;319(1-2):32-6. doi: 10.1016/j.jns.2012.05.027. Epub 2012 May 31. Review.
  130. A review of cases of human cysticercosis in Canada. Del Brutto OH. Can J Neurol Sci. 2012 May;39(3):319-22. Review.
  131. Neurocysticercosis in Western Europe: a re-emerging disease? Del Brutto OH. Acta Neurol Belg. 2012 Dec;112(4):335-43. doi: 10.1007/s13760-012-0068-3. Epub 2012 Apr 18. Review.
  132. Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. White CL, Szychowski JM, Roldan A, Benavente MF, Pretell EJ, Del Brutto OH, Kase CS, Arauz A, Meyer BC, Meissner I, Demaerschalk BM, McClure LA, Coffey CS, Pearce LA, Conwit R, Irby LH, Peri K, Pergola PE, Hart RG, Benavente OR; SPS3 Investigators. J Stroke Cerebrovasc Dis. 2013 Aug;22(6):764-74. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.002. Epub 2012 Apr 17.
  133. Reduced percentage of neurocysticercosis cases among patients with late-onset epilepsy in the new millennium. Del Brutto OH, Del Brutto VJ. Clin Neurol Neurosurg. 2012 Nov;114(9):1254-6. doi: 10.1016/j.clineuro.2012.03.033. Epub 2012 Apr 12.
  134. Neurocysticercosis in Australia: still free of autochthonous cases? Del Brutto OH. Med J Aust. 2012 Apr 2;196(6):385. No abstract available.
  135. Characteristics of 478 very old neurologic outpatients evaluated over 20 years in Guayaquil, Ecuador. Del Brutto VJ, Del Brutto OH. Acta Neurol Belg. 2012 Jun;112(2):161-5. doi: 10.1007/s13760-012-0023-3. Epub 2012 Jan 24.
  136. Neurocysticercosis among international travelers to disease-endemic areas. Del Brutto OH. J Travel Med. 2012 Mar-Apr;19(2):112-7. doi: 10.1111/j.1708-8305.2011.00592.x. Epub 2012 Feb 24. Review.
  137. Reversible posterior leukoencephalopathy in a venomous snake (Bothrops asper) bite victim. Delgado ME, Del Brutto OH. Am J Trop Med Hyg. 2012 Mar;86(3):496-8. doi: 10.4269/ajtmh.2012.11-0610.
  138. Steroid-dependant idiopathic caseating intracranial granuloma. Del Brutto OH, Mena IX.
  139. Can J Neurol Sci. 2012 Mar;39(2):251-2. No abstract available.
  140. Neurocysticercosis: a review. Del Brutto OH. ScientificWorldJournal. 2012;2012:159821. doi: 10.1100/2012/159821. Epub 2012 Jan 4. Review.
  141. Changing pattern of neurocysticercosis in an urban endemic center (Guayaquil, Ecuador). Del Brutto OH, Del Brutto VJ. J Neurol Sci. 2012 Apr 15;315(1-2):64-6. doi: 10.1016/j.jns.2011.11.034. Epub 2011 Dec 16.
  142. Calcified neurocysticercosis among patients with primary headache. Del Brutto OH, Del Brutto VJ. Cephalalgia. 2012 Feb;32(3):250-4. doi: 10.1177/0333102411433043. Epub 2011 Dec 15.
  143. Neurological complications of venomous snake bites: a review. Del Brutto OH, Del Brutto VJ. Acta Neurol Scand. 2012 Jun;125(6):363-72. doi: 10.1111/j.1600-0404.2011.01593.x. Epub 2011 Oct 15. Review.
  144. Workshop report: Developing an international collaborative research network in neurocysticercosis and epilepsy. Burneo JG, Del Brutto O, Delgado-Escueta AV, Gonzalez AE, Medina MT, Montano SM, Moyano LM, Nash T, Roman G, Singh G, White AC Jr, Wiebe S, Garcia HH. Epilepsia. 2009 May;50(5):1289-90. doi: 10.1111/j.1528-1167.2008.01912.x. No abstract available.
  145. Infections and stroke. Del Brutto OH. Handb Clin Neurol. 2009;93:851-72. doi: 10.1016/S0072-9752(08)93043-8. Review. No abstract available.
  146. Strategies for the elimination of taeniasis/cysticercosis. García HH, González AE, Del Brutto OH, Tsang VC, Llanos-Zavalaga F, Gonzalvez G, Romero J, Gilman RH; Cysticercosis Working Group in Peru. J Neurol Sci. 2007 Nov 15;262(1-2):153-7. Epub 2007 Aug 2. Review.
  147. Treatment of neurocysticercosis: current status and future research needs. Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, Proaño JV, Takayanagui OM, Gonzalez AE, Butman JA, DeGiorgio C, Del Brutto OH, Delgado-Escueta A, Evans CA, Gilman RH, Martinez SM, Medina MT, Pretell EJ, Teale J, Garcia HH. Neurology. 2006 Oct 10;67(7):1120-7. Review.
  148. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Del Brutto OH, Roos KL, Coffey CS, García HH. Ann Intern Med. 2006 Jul 4;145(1):43-51.
  149. Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst. Bustos JA, Pretell EJ, Llanos-Zavalaga F, Gilman RH, Del Brutto OH, Garcia HH; Cysticercosis Working Group in Peru. Clin Neurol Neurosurg. 2006 Feb;108(2):193-4. Epub 2005 Jan 19. No abstract available.
  150. [Neurocysticercosis: up-dating in diagnosis and treatment]. Del Brutto OH. Neurologia. 2005 Oct;20(8):412-8. Review. Spanish.
  151. Neurocysticercosis. Del Brutto OH. Semin Neurol. 2005 Sep;25(3):243-51. Review.
  152. Neurocysticercosis: updated concepts about an old disease. Garcia HH, Del Brutto OH; Cysticercosis Working Group in Peru. Lancet Neurol. 2005 Oct;4(10):653-61. Review.
  153. Review of neurocysticercosis. Sotelo J, Del Brutto OH. Neurosurg Focus. 2002 Jun 15;12(6):e1. Review.
  154. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Del Brutto OH, Santibáñez R, Idrovo L, Rodrìguez S, Díaz-Calderón E, Navas C, Gilman RH, Cuesta F, Mosquera A, Gonzalez AE, Tsang VC, García HH. Epilepsia. 2005 Apr;46(4):583-7.
  155. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Garcia HH, Del Brutto OH, Nash TE, White AC Jr, Tsang VC, Gilman RH. Am J Trop Med Hyg. 2005 Jan;72(1):3-9. Review.
  156. Stroke in rural Ecuador: a three-phase, door-to-door survey. Del Brutto OH, Idrovo L, Mosquera A, Navas C, Santibáñez R, Cuesta F, Díaz-Calderón E. Neurology. 2004 Nov 23;63(10):1974-5.
  157. [Validation of a screening questionnaire for stroke detection in Spanish-speaking communities]. Del Brutto OH, Idrovo L, Mosquera A, Díaz-Calderón E, Santibáñez R, Navas C, Cuesta F. Rev Neurol. 2004 Aug 16-31;39(4):301-4. Spanish.
  158. Door-to-door survey of major neurological diseases in rural Ecuador–the Atahualpa Project: methodological aspects. Del Brutto OH, Idrovo L, Santibáñez R, Díaz-Calderón E, Mosquera A, Cuesta F, Navas C. Neuroepidemiology. 2004 Nov-Dec;23(6):310-6. Epub 2004 Aug 5.
  159. [Relationship between body temperature and prognosis, and neuroprotective effect of hypothermia in acute stroke patients]. del Brutto OH. Rev Neurol. 2004 Jun 1-15;38(11):1050-5. Review. Spanish.
  160. Calcific neurocysticercosis and epileptogenesis. Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, Duron RM, Evans CA, Gilman RH, Gonzalez AE, Loeb JA, Medina MT, Pietsch-Escueta S, Pretell EJ, Takayanagui OM, Theodore W, Tsang VC, Garcia HH. Neurology. 2004 Jun 8;62(11):1934-8. Review.
  161. Validation of intracerebral hemorrhage scores for patients with pontine hemorrhage. Del Brutto OH, Campos X. Neurology. 2004 Feb 10;62(3):515-6. No abstract available.
  162. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, Herrera G, Evans CA, Gonzalez AE; Cysticercosis Working Group in Peru. N Engl J Med. 2004 Jan 15;350(3):249-58.
  163. Stroke in South America: a systematic review of incidence, prevalence, and stroke subtypes. Saposnik G, Del Brutto OH; Iberoamerican Society of Cerebrovascular Diseases. Stroke. 2003 Sep;34(9):2103-7. Epub 2003 Aug 7. Review.
  164. Imaging findings in neurocysticercosis. García HH, Del Brutto OH. Acta Trop. 2003 Jun;87(1):71-8. Review.
  165. Stroke following Bothrops spp. snakebite. Mosquera A, Idrovo LA, Tafur A, Del Brutto OH. Neurology. 2003 May 27;60(10):1577-80. Review.
  166. Commentary: Headache in South America. Del Brutto OH. BMJ. 2002 Oct 19;325(7369):881-6. No abstract available.
  167. Current consensus guidelines for treatment of neurocysticercosis. García HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, Rajshekhar V, Tsang VC, Schantz PM, Allan JC, Flisser A, Correa D, Sarti E, Friedland JS, Martinez SM, Gonzalez AE, Gilman RH, Del Brutto OH. Clin Microbiol Rev. 2002 Oct;15(4):747-56. Review.
  168. [Cerebrovascular disease in the tropics]. del Brutto OH. Rev Neurol. 2001 Oct 16-31;33(8):750-62. Review. Spanish.
  169. [Classification of the cerebrovascular diseases. Iberoamerican Cerebrovascular diseases Society]. Díez-Tejedor E, del Brutto O, Alvarez Sabín J, Muñoz M, Abiusi G; Sociedad Iberoamericana de Enfermedades Cerebrovasculares. Rev Neurol. 2001 Sep 1-15;33(5):455-64. Review. Spanish.
  170. Proposed diagnostic criteria for neurocysticercosis. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, Schantz PM, Evans CA, Flisser A, Correa D, Botero D, Allan JC, Sarti E, Gonzalez AE, Gilman RH, García HH. Neurology. 2001 Jul 24;57(2):177-83. Review.
  171. Chagas’ disease. Del Brutto OH. Lancet. 2001 Jul 7;358(9275):74. No abstract available.
  172. [Cysticercosis of the cerebellopontine angle: treatment with single-dose praziquantel]. del Brutto OH. Rev Neurol. 2000 Nov 1-15;31(9):835-7. Spanish.
  173. Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. TheCysticercosis Working Group in Perú. Gilman RH, Del Brutto OH, García HH, Martínez M. Neurology. 2000 Oct 10;55(7):1062. No abstract available.
  174. [Gliomatosis cerebri: clinico-pathological and neuroimaging characteristics and the results of treatment with radiotherapy]. Mena IX, Olivares DA, del Brutto OH, Leone-Stay G. Rev Neurol. 2000 Jul 16-31;31(2):101-6. Spanish.
  175. Neurocysticercosis and oncogenesis. Del Brutto OH, Dolezal M, Castillo PR, García HH. Arch Med Res. 2000 Mar-Apr;31(2):151-5. Review.
  176. A proposal to declare neurocysticercosis an international reportable disease. Román G, Sotelo J, Del Brutto O, Flisser A, Dumas M, Wadia N, Botero D, Cruz M, Garcia H, de Bittencourt PR, Trelles L, Arriagada C, Lorenzana P, Nash TE, Spina-França A. Bull World Health Organ. 2000;78(3):399-406.
  177. [Central nervous system mycotic infections]. del Brutto OH. Rev Neurol. 2000 Mar 1-15;30(5):447-59. Review. Spanish.
  178. Brain cysticercosis. Sotelo J, Del Brutto OH. Arch Med Res. 2000 Jan-Feb;31(1):3-14. Review. No abstract available.
  179. Taenia solium cysticercosis. Garcia HH, Del Brutto OH. Infect Dis Clin North Am. 2000 Mar;14(1):97-119, ix. Review.
  180. [The Guayaquil Declaration]. Del Brutto OH. Rev Neurol. 1999 Feb 1-15;28(3):237. Spanish. No abstract available.
  181. [Neurocysticercosis]. del Brutto OH. Rev Neurol. 1999 Sep 1-15;29(5):456-66. Review. Spanish.
  182. Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú. García HH, Del Brutto OH. Neurology. 1999 Oct 22;53(7):1582-4.
  183. Non-traumatic intracerebral hemorrhage in young adults living in Guayaquil, Ecuador (South America): analysis of 151 patients. Del Brutto OH, Sánchez J, Campos X, Santos J, Mosquera A. Funct Neurol. 1999 Jan-Mar;14(1):21-8.
  184. Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Del Brutto OH, Campos X, Sánchez J, Mosquera A. Neurology. 1999 Mar 23;52(5):1079-81.
  185. Brainstem tuberculoma mimicking glioma: the role of antituberculous drugs as a diagnostic tool. Del Brutto OH, Mosquera A. Neurology. 1999 Jan 1;52(1):210-1. No abstract available.
  186. [The Buenos Aires agreement].del Brutto OH, Bueri JA, Culebras A, Matías-Guiu J, Medina MT, Pérez GE. Rev Neurol. 1998 Apr;26(152):576-7. Spanish. No abstract available.
  187. [Bilateral medial bulbar infarct related to dolichoectasia of the vertebral artery]. Del Brutto OH, Sánchez J, Mosquera A, Campos X. Rev Neurol. 1998 Sep;27(157):511-3. Spanish.
  188. [Neurocysticercosis in children: clinical and radiological analysis and prognostic factors in 54 patients]. del Brutto OH. Rev Neurol. 1997 Nov;25(147):1681-4. Spanish.
  189. International submissions to Neurology. Del Brutto OH. Neurology. 1997 Oct;49(4):1185-6. No abstract available.
  190. Neurocysticercosis among patients with cerebral gliomas. Del Brutto OH, Castillo PR, Mena IX, Freire AX. Arch Neurol. 1997 Sep;54(9):1125-8.
  191. [Toward the federation of neurological journals in Spanish?]. Del Brutto O, Culebras A, Matías-Guiu J, Pérez GE. Rev Neurol. 1997 Aug;25(144):1198. Spanish. No abstract available.
  192. Neurocysticercosis. Del Brutto OH. Curr Opin Neurol. 1997 Jun;10(3):268-72. Review.
  193. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients. Del Brutto OH. J Neurol Neurosurg Psychiatry. 1997 Jun;62(6):659-61.
  194. Clues to prevent cerebrovascular hazards of cysticidal drug therapy. Del Brutto OH. Stroke. 1997 May;28(5):1088. No abstract available.
  195. Is the course of neurocysticercosis modified by treatment with anthelmintic agents? Del Brutto OH. Arch Intern Med. 1997 Jan 13;157(1):128-30. No abstract available.
  196. [Angiographic findings among Ecuadorian metis population with occlusive cerebrovascular disease of the anterior circulation]. del Brutto OH, Campos X, Tomalá M, Parrales H, Sánchez X. Rev Neurol. 1997 Jan;25(137):40-3. Spanish.
  197. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC, Schantz PM. J Neurol Sci. 1996 Oct;142(1-2):1-6. Review.
  198. [Cerebrovascular complications of Takayasu’s disease]. del Brutto OH, Lara-Terán J, Sánchez J, Lara-Montiel J. Rev Neurol. 1996 Jul;24(131):803-5. Spanish.
  199. [Lost science in the third world]. del Brutto OH. Rev Neurol. 1996 May;24(129):505. Spanish. No abstract available.
  200. Cysticercosis. Sotelo J, Del Brutto OH, Roman GC. Curr Clin Top Infect Dis. 1996;16:240-59. Review. No abstract available.
  201. Cysticercosis mimicking brain tumor: the role of albendazole as a diagnostic tool. Del Brutto OH, Quintero LA. Clin Neurol Neurosurg. 1995 Aug;97(3):256-8.
  202. Single parenchymal brain cysticercus in the acute encephalitic phase: definition of a distinct form of neurocysticercosis with a benign prognosis. Del Brutto OH. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):247-9.
  203. Medical treatment of cysticercosis–effective. del Brutto OH. Arch Neurol. 1995 Jan;52(1):102-4. No abstract available.
  204. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Del Brutto OH. Neurology. 1994 Sep;44(9):1706-9.
  205. Cysticercus granuloma. Del Brutto OH. Neurology. 1994 Apr;44(4):777. No abstract available.
  206. Stroke subtypes among Hispanics living in Guayaquil, Ecuador. Results from the Luis Vernaza Hospital Stroke Registry. Del Brutto OH, Mosquera A, Sánchez X, Santos J, Noboa CA. Stroke. 1993 Dec;24(12):1833-6.
  207. Therapy for neurocysticercosis: a reappraisal. Del Brutto OH, Sotelo J, Roman GC.Clin Infect Dis. 1993 Oct;17(4):730-5. Review.
  208. Case 8-1993: cysticercosis. Del Brutto OH. N Engl J Med. 1993 Sep 9;329(11):813. No abstract available.
  209. The use of albendazole in patients with single lesions enhanced on contrast CT. Del Brutto OH. N Engl J Med. 1993 Feb 4;328(5):356-7. No abstract available.
  210. Medical management of neurocycticercosis. Del Brutto OH. Int J Antimicrob Agents. 1993;3(2):133-7. No abstract available.
  211. Albendazole therapy for giant subarachnoid cysticerci. Del Brutto OH, Sotelo J, Aguirre R, Díaz-Calderón E, Alarcón TA. Arch Neurol. 1992 May;49(5):535-8.
  212. Cysticercosis and cerebrovascular disease: a review. Del Brutto OH. J Neurol Neurosurg Psychiatry. 1992 Apr;55(4):252-4. Review.
  213. Epilepsy due to neurocysticercosis: analysis of 203 patients. Del Brutto OH, Santibañez R, Noboa CA, Aguirre R, Díaz E, Alarcón TA. Neurology. 1992 Feb;42(2):389-92.
  214. Bilateral internuclear ophthalmoplegia after smoking “crack” cocaine. Díaz-Calderón E, Del Brutto OH, Aguirre R, Alarcón TA. J Clin Neuroophthalmol. 1991 Dec;11(4):297-9.
  215. Genetic pattern of the HLA system: HLA A, B, C, DR, and DQ antigens in Mexican patients with parenchymal brain cysticercosis. Del Brutto OH, Granados G, Talamas O, Sotelo J, Gorodezky C. Hum Biol. 1991 Feb;63(1):85-93.
  216. Albendazole therapy for neurocysticercosis. Del Brutto OH. Arch Neurol. 1990 Dec;47(12):1278-9. No abstract available.
  217. Multiple brain abscesses from isolated cerebral mucormycosis. Escobar A, Del Brutto OH. J Neurol Neurosurg Psychiatry. 1990 May;53(5):431-3.
  218. Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report. del Brutto OH, Sotelo J. J Neurosurg. 1990 May;72(5):816-7.
  219. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. Sotelo J, del Brutto OH, Penagos P, Escobedo F, Torres B, Rodriguez-Carbajal J, Rubio-Donnadieu F. J Neurol. 1990 Apr;237(2):69-72.
  220. MR imaging in cysticercotic encephalitis. Del Brutto OH, Zenteno MA, Salgado P, Sotelo J. AJNR Am J Neuroradiol. 1989 Sep-Oct;10(5 Suppl):S18-20. No abstract available.
  221. Acquired epileptic aphasia (the Landau-Kleffner syndrome) due to neurocysticercosis. Otero E, Cordova S, Diaz F, Garcia-Teruel I, Del Brutto OH. Epilepsia. 1989 Sep-Oct;30(5):569-72.
  222. Occlusion of the middle cerebral artery due to cysticercotic angiitis. Rodriguez-Carbajal J, Del Brutto OH, Penagos P, Huebe J, Escobar A. Stroke. 1989 Aug;20(8):1095-9.
  223. Brain-stem tuberculoma. An analysis of 11 patients. Talamás O, Del Brutto OH, García-Ramos G. Arch Neurol. 1989 May;46(5):529-35.
  224. Lacunar syndrome due to neurocysticercosis. Barinagarrementeria F, Del Brutto OH. Arch Neurol. 1989 Apr;46(4):415-7.
  225. Inflammatory arteriopathies and pure motor hemiplegia. Del Brutto O, Barinagarrementeria F. Arch Neurol. 1989 Apr;46(4):361. No abstract available.
  226. Intracranial tuberculoma: MR imaging. Salgado P, Del Brutto OH, Talamás O, Zenteno MA, Rodríguez-Carbajal J. Neuroradiology. 1989;31(4):299-302.
  227. Neurocysticercosis: an update. Del Brutto OH, Sotelo J. Rev Infect Dis. 1988 Nov-Dec;10(6):1075-87. Review.
  228. Short course of albendazole therapy for neurocysticercosis. Sotelo J, Penagos P, Escobedo F, Del Brutto OH. Arch Neurol. 1988 Oct;45(10):1130-3.
  229. Neurocysticercosis and pure motor hemiparesis. Barinagarrementeria F, Del Brutto OH. Stroke. 1988 Sep;19(9):1156-8.
  230. Delayed CSF reaction to praziquantel. Del Brutto OH. Lancet. 1988 Aug 6;2(8606):341. No abstract available.
  231. Intrasellar cysticercosis. Del Brutto OH, Guevara J, Sotelo J. J Neurosurg. 1988 Jul;69(1):58-60.
  232. Ataxic hemiparesis from parenchymal brain cysticercosis. Barinagarrementeria F, Del Brutto OH. J Neurol. 1988 May;235(5):325. No abstract available.
  233. [Cerebral abscesses. Current status and perspectives]. Del Brutto OH, Escobar A. Rev Invest Clin. 1988 Apr-Jun;40(2):177-89. Review. Spanish. No abstract available.
  234. Ataxic hemiparesis from cysticercosis. Barinagarementería F, Del Brutto OH, Otero E.Arch Neurol. 1988 Mar;45(3):246. No abstract available.
  235. Sex-related severity of inflammation in parenchymal brain cysticercosis. Del Brutto OH, García E, Talámas O, Sotelo J. Arch Intern Med. 1988 Mar;148(3):544-6.
  236. Lateral pontine hemorrhage: reappraisal of benign cases. Del-Brutto OH, Noboa CA, Barinagarrementería F. Stroke. 1987 Sep-Oct;18(5):954-6.
  237. Does Valsalva’s maneuver precipitate paradoxical brain embolism in healthy individuals? Del Brutto O, Lara J, de Lara A. Arch Neurol. 1987 Sep;44(9):896. No abstract available.
  238. Unilateral third nerve palsy and somnolent mutism. Zermeño F, Del Brutto OH, Van Wielink G, Nader J. J Clin Neuroophthalmol. 1987 Jun;7(2):93-7.
  239. Therapy of neurocysticercosis. Sotelo J, Del Brutto OH. Childs Nerv Syst. 1987;3(4):208-11. Review.

Otras Revistas Médicas (Scopus, Latindex, NO PubMED)

  1. Noboa CA, Del Brutto OH. CT findings in cyanide-induced parkinsonism. Neurol Colombia 1986;10:80-82.
  2. Noboa C, Ferreti C, Del Brutto O, Caicedo J. Calcificación de los ganglios basales y nucleos dentados cerebelosos. Neurol Colombia 1986;10:27-32.
  3. Noboa CA, Del Brutto OH. Progressive extrapyramidal manifestation with an abnormal CT scan. Clini Pearls 1986;8(5):9-10.
  4. Del Brutto OH, Bassanini M, Noboa CA. Agenesia del cuerpo calloso diagnosticada por ultrasonido: reporte de 1 caso. Neurologia-Neurocirugia-Psiquiatria (Mex) 1987;27:39-41.
  5. Del Brutto OH, Sotelo J. Another disturbing ring. Clini Pearls 1988;11(1):7-8.
  6. Noboa CA, Del Brutto OH, Sotelo J. Neurocisticercosis: aspectos clínicos, diagnósticos y terapéuticos. Rev Neurol Arg 1988;14:86-100.
  7. Del Brutto O, Sotelo J. Some unusual manifestations of neurocysticercosis. Neurologia-Neurocirugia-Psiquiatria (Mex) 1989;29:23-26.
  8. Del Brutto OH. Diagnosis and management of neurocysticercosis. J Trop Geogr Neurol 1992;2:1-9.
  9. Talamas O, Del Brutto OH, Revuelta R. Tuberculoma intracraneal: estudio de 40 pacientes. Rev Ecuat Neurol 1992;1:14-26.
  10. Alarcón TA, Hidalgo C, Santibañez R, Aguirre R, Díaz-Calderón E, Del Brutto OH. Paraparesia espástica tropical en el Ecuador: comunicación preliminar. Rev Ecuat Neurol 1992;1:54-60.
  11. Alarcón T, Santibañez R, Aguirre C, Del Brutto O, Díaz E, Navas C. Paraparesia espástica tropical en el Ecuador. Ann Med Cirugía 1992;5:20-23.
  12. Del Brutto OH, Sotelo J. Etiopatogenia de la neurocisticercosis. Rev Ecuat Neurol 1993;2:22-32.
  13. Tomalá M, Noboa CA, Del Brutto OH. Hemorragias cerebrales no traumáticas en sujetos jovenes. Rev Ecuat Neurol 1993;2:4-9.
  14. Del Brutto OH. Angeitis del sistema nervioso central. Rev Ecuat Neurol 1993;2:71-74.
  15. Del Brutto OH. CT findings in neurologically normal adults with a single generalized seizure. J Epilepsy 1994;7:38-40.
  16. Del Brutto OH. Complicaciones neurológicas del sindrome de inmunodeficiencia adquirida. Rev Hosp Psiquiat Habana 1994;34:169-178.
  17. Campos X, Santos J, Del Brutto OH. Hemorragias de la cabeza del núcleo caudado. Rev Ecuat Neurol 1994;3:14-17.
  18. Mena I, Orellana J, Del Brutto OH. Disecciones carotídeas post-traumáticas. Rev Ecuat Neurol 1994;3:63-67.
  19. Del Brutto OH, Campos X, Tomalá M, Parrales H, Sanchez J. Angiographic findings in Ecuadorian mestizos with anterior circulation occlusive cerebrovascular disease. Rev Ecuat Neurol 1995;4:47-51.
  20. Del Brutto OH, Sanchez X, Parrales H. Neuromielitis óptica (enfermedad de Devic): reporte de un caso estudiado con MRI. Rev Ecuat Neurol 1995;4:31-34.
  21. Del Brutto OH, Campos X. Discontinuation of antiepileptic drugs in patients with calcified neurocysticercosis. J Epilepsy 1996;9:331-333.
  22. Saez de Ocariz MM, Nader JA, Del Brutto OH, Santos JA. Cerebrovascular complications of neurosyphilis: the return of an old problem. Cerebrovasc Dis 1996;6:195-201.
  23. Del Brutto OH. Epilepsia secundaria a neurocisticercosis. Rev Ecuat Neurol 1996;5:12-17.
  24. Sánchez J, Campos X, Del Brutto OH. Acute bilateral cerebellar infarction due to occlusion of a single posterior inferior cerebellar artery. Rev Ecuat Neurol 1996;5:66-68.
  25. Del Brutto OH. Invasive cestodes (cysticercosis and hydatid disease). Medicine Series 1997;25:84-87.
  26. Sánchez J, Del Brutto OH. Abscesos cerebrales piógenos. Rev Ecuat Neurol 1997;6:25-36.
  27. Del Brutto OH, Noboa R. Conocimientos de cisticercosis en pacientes neurológicos en un medio del alta prevalencia. Rev Ecuat Neurol 1998;7:23-27.
  28. Campos X, Del Brutto OH. Formas clínicas de presentación en tumores cerebrales. Oncología 1998;8:41-46.
  29. Del Brutto OH, Castillo P. Neurocisticercosis y oncogénesis: estado actual y perspectivas de investigación. Oncología 1998;8:47-50.
  30. Del Brutto OH, Sánchez J. Linfoma primario del sistema nervioso central. Oncología 1998;8:166-169.
  31. Del Brutto OH, Mosquera A. Infecciones del sistema nervioso por helmintos. Rev Ecuat Neurol 1998;7:75-84.
  32. Del Brutto OH. Complicaciones cerebrovasculares de la neurocisticercosis. Rev Ecuat Neurol 1998;7:103-104
  33. Bueri JA, Culebras A, Del Brutto OH, Matías-Guiu J, Medina MT, Pérez G. El acuerdo de Buenos Aires. Rev Ecuat Neurol 1998;7:1-4
  34. Del Brutto OH, Campos X, Sánchez J, Mosquera A. Single-day praziquantel versus one-week albendazole for neurocysticercosis. Neurology 1999;52:1079-1081
  35. Del Brutto OH. Problemas en el diagnóstico de la demencia vascular. Rev Ecuat Neurol 1999;8:23-25.
  36. Sánchez J, Del Brutto OH. Delayed cerebral injury following a gunshot injury of the neck. Rev Ecuat Neurol 1999;8:31.
  37. Del Brutto OH. How to write a scientific paper. Arch Neurosciences (Mex) 1999;4:101-103.
  38. Del Brutto OH. Neurocisticercosis. Revista Hondureña de Neurociencias 1999;3:22-35.
  39. Del Brutto OH. Medical therapy for neurocysticercosis: indications, risks, and benefits. Rev Ecuat Neurol 2000;9:13-15
  40. Del Brutto OH. Taenia (including cysticercosis) and hydatid disease. Medicine Series 2001;29(6):74-77.
  41. Del Brutto OH. Aspectos prácticos de las infecciones bacterianas del sistema nervioso central. Rev Ecuat Neurol 2002;11:23-32.
  42. Del Brutto Oh, Idrovo L, Santibáñez R, Díaz-Calderón E, Mosquera A, Cuesta F, Navas C. Estudio puerta-a-puerta de enfermedades neurológicas en Atahualpa, una población rural del litoral ecuatoriano—Metodología y definiciones operacionales. Rev Ecuat Neurol 2003;12:39-52.
  43. Del Brutto OH. Neuroprotección no farmacológica en el manejo de pacientes con ictus agudo. Rev Ecuat Neurol 2003;12:66-78.
  44. Del Brutto OH. Taenia (including cysticercosis and hydatid disease). Medicine Series. 2005;33(8):70-73.
  45. Del Brutto OH. Inicio de una nueva etapa de la Revista Ecuatoriana de Neurología. Rev Ecuat Neurol 2005;14:5.

Libros

  1. Del Brutto OH, Sotelo J, Román GC. Neurocysticercosis: a clinical handbook, Lisse, Holland: Swets & Zeitlinger, 1998
  2. Del Brutto OH. Neurocisticercosis. México: Series del Instituto Nacional de Neurología y Neurocirugía, MVS, 2000.
  3. Del Brutto OH, Garcia HH. Cysticercosis of the human nervous system. Heildelberg, Germany: Springer, 2014
  4. Garcia HH, Tanowitz HB, Del Brutto OH. Neuroparasitology and tropical Neurology. Handbook of Clinical Neurology, vol 114 (3rd series). Amsterdam, The Netherlands: Elsevier, 2014.

Capítulos de Libro

  1. Sotelo J, Del Brutto OH. Diagnóstico y tratamiento de la cisticercosis cerebral. In: Rodriguez-Carbajal J, Escobar A, eds. Libro homenaje al doctor y profesor Manuel M. Velasco Suarez en el 50 aniversario profesional (1938-1988). México: Editorial Progreso, 1988:382-392.
  2. Del Brutto OH. Cysticercosis. In: Feldmann E, ed. Current diagnosis in neurology. St. Louis: Mosby, 1994:125-129.
  3. Sotelo J, Del Brutto OH, Roman GC. In: Remington JS, Swartz MN, eds. Current clinical topics in infectious diseases. Boston: Blackwell Science, 1996:240-259.
  4. Del Brutto OH. Enfermedades infecciosas, in: Micheli FE, Fernandez-Pardal MM, eds. Neurología en el anciano. Buenos Aires: Editorial Panamericana, 1996:389-400.
  5. Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VCW, Schantz PM. Diagnostic criteria for human cysticercosis. In: García HH, Martínez SM, eds. Teniasis/cisticercosis por T. Solium. Lima: Editorial Universo, 1996:133-138.
  6. Del Brutto OH. Cisticercosis en fase encefalítica. In: García HH, Martínez SM, eds. Teniasis/cisticercosis por T. Solium. Lima: Editorial Universo, 1996:161-168.
  7. Del Brutto OH. Epilepsia y cisticercosis. In: García HH, Martínez SM, eds. Teniasis/cisticercosis por T. Solium. Lima: Editorial Universo, 1996:185-192.
  8. Del Brutto OH. Epilepsia y neurocisticercosis. In: Arriagada C, Nogales-Gaete J, Apt W, eds. Neurocisticercosis. Santiago de Chile: Arrynog Ediciones, 1997:153-160.
  9. Del Brutto OH. Infections and stroke. In: Ginsberg MD, Bogousslavsky J, eds. Cerebrovascular disease, Pathophysiology, Diagnosis, and Management, Malden: Blackwell Science, 1998:1628-1646.
  10. Del Brutto OH. Parasitic infectious disorders. In: Fisher M, Bogousslavsky J, eds. Textbook of Neurology, Boston: Butterworth-Heinemann, 1998:604-615.
  11. Del Brutto OH. Neurocysticercosis. In: Gilchrist JM, ed. Prognosis in neurology, Boston: Butterworth-Heinemann, 1998:257-261.
  12. Del Brutto OH. Causas tropicales de enfermedad cerebrovascular, In: Barinagarrementeria F, Cantú C, eds. Enfermedad Vascular Cerebral, México: McGraw Hill Interamericana, 1998:295-305.
  13. Del Brutto OH. Nonviral forms of encephalitis. In: Joynt RJ, Griggs RC, eds. Clinical Neurology. Lippincont Williams & Wilkins, vol 2, chap 27, 1998.
  14. Sotelo J, Del Brutto OH. In: Chopra JS, Sawhney IMS, eds. Neurology in Tropics, New Delhi: B.I. Churchill Livingstone, 1999:227-243.
  15. Del Brutto OH. Solitary cysticercus granuloma in Latin America. In: Rajshekhar V, Chandy MJ, eds. Solitary cysticercus granuloma: the disappearing CT lesion, Himayatnagar: Orient Longman Limited, 2000:153-166.
  16. Del Brutto OH. Neurocysticercosis. In: Misra UK, ed. Tropical Neurology, Georgetown, TX: Landes Bioscience, 2000:268-296
  17. García HH, Del Brutto OH. Inf Dis Clin North America, WB Saunders Co, 2000;14:97-119.
  18. Noboa CA, Del Brutto OH. Infecciones del sistema nervioso. In: Micheli F, ed. Neurología, Buenos Aires: Editorial Panamericana, 2000:447-472
  19. Del Brutto OH, Medina MT, Durón R. Epilepsia y neurocisticercosis. In: Medina MT, Cháves F, Chinchilla N, Gracia F, eds. Las Epilepsias en Centro América, Tegucigalpa, Honduras: Scancolor Prepress, 2001:213-225.
  20. Del Brutto OH. Meningeal cysticercosis. In: Singh G, Prabhakar S. Taenia solium cysticercosis. From basic to clinical science. Wallingford, UK: CABI Publishing, 2002:177-188.
  21. Del Brutto OH, García HH, Prabhakar S. Heavy multilesional cysticercotic syndromes. In: Singh G, Prabhakar S. Taenia solium cysticercosis. From basic to clinical science. Wallingford, UK: CABI Publishing, 2002:189-198.
  22. Del Brutto OH. Nonviral forms of encephalitis. In: Joynt RJ, Griggs RC, eds. Baker and Joynt’s Clinical Neurology on CD-ROM. Lippincont Williams & Wilkins, 2002.
  23. Del Brutto OH. Neurocisticercosis. In: Micheli F, Noguès MA, Asconapé JJ, Fernández-Pardal MM, Biller J, eds. Tratado de Neurología Clínica. Buenos Aires, Argentina: Editorial Médica Panamericana, 2002:1009-1020.
  24. Del Brutto OH, Sotelo J. Taenia solium. In: Miliotis MD, Bier JW, eds. Foodborne Pathogens. New York, NY: Marcel Dekker Inc, 2003:525-538.
  25. Del Brutto OH. Helminthic infections of the central nervous system. In: Noseworthy JH, ed. Neurological therapeutics. Principles and practice. New York, NY: Martin Dunitz, 2003: 1021-1038.
  26. Del Brutto OH. Infecciones del sistema nervioso. In: Casas Parera I, Barreiro de Madariaga L, Carmona S, Rugilo C, eds. Manual de Neurologìa. Bogotà, Colombia: Grupo Guìa, 2004:197-210.
  27. Del Brutto OH. Helminthic infections. In: Roos K, ed. Principles of Neurologic Infectious Diseases. Mc-Graw-Hill Medical Publishing, 2005:241-262.
  28. Nash TE, García HH, Rajshekhar V, Del Brutto OH. Clinical cysticercosis: diagnosis and treatment. In: Murrell KD, ed. WHO/FAO/OIE Guidelines for the surveillance, prevention and control of taeniosis/cysticercosis. WHO, Paris, France, 2005:11-25.
  29. Del Brutto OH. Encephalitis due to parasites. in: Halperin JJ (ed). Encephalitis. Diagnosis and treatment. Informa healthcare: New York, NY, 2008: 239-253

Ponencias

  1. Platform presentation: Lateral pontine hemorrhages. IX Annual Meeting of the Mexican Academy of Neurology, Guadalajara, Mexico, November 1986.
  2. Platform presentation: Ataxic hemiparesis from cysticercosis. XI Annual Meeting of the Mexican Academy of Neurology, Chihuahua, Mexico, November 1987.
  3. Platform presentation: Neurocysticercose en pays d’endemie (Mexique): interet de l’IRM. Annual Meeting of the French Society of Neuroradiology, Paris, France, December 1987.
  4. Poster presentation: MHC restriction mechanisms of immune response in human neurocysticercosis. XIV Annual Meeting of the American Society for Histocompatibility and Immunogenetics, San Francisco, CA, USA, October 1988.
  5. Platform presentation: MR imaging of intracranial tuberculoma: comparison with CT. XXIII Latinoamerican Congress of Neurosurgery, Acapulco, Mexico, November 1988.
  6. Platform presentation: Intracranial tuberculomas: analysis of 37 patients. XII Annual Meeting of the Mexican Academy of Neurology, Zacatecas, Mexico, November 1988.
  7. Platform presentation: Lacunar syndromes due to neurocysticercosis. XII Annual Meeting of the Mexican Academy of Neurology, Zacatecas, Mexico, November 1988.
  8. Platform presentation: Brainstem Tuberculomas. IV Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1989.
  9. Platform presentation: Therapeutic regimen of anticysticercal drugs in patients with parenchymal neurocysticercosis. IV Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1989.
  10. Platform presentation: Occlusion of the middle cerebral artery due to cysticercotic angiitis. IV Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1989.
  11. Poster presentation: Epilepsy due to neurocysticercosis: analysis of 203 patients. 43rd Annual Meeting of the American Academy of Neurology, Boston, MA, USA, April 1991.
  12. Platform presentation: Late-onset epilepsy in Ecuador. V Ecuadorian Congress of Neurology, Quito, Ecuador, May 1991.
  13. Platform presentation: Tropical spastic paraparesis in Ecuador. V Ecuadorian Congress of Neurology, Quito, Ecuador, May 1991.
  14. Platform presentation: Albendazole therapy for giant subarachnoid cysticercus. I Ecuadorian Congress of Neurosurgery, Guayaquil, Ecuador, November 1991.
  15. Poster presentation: Single parenchymal brain cysticercus in the acute encephalitic phase: definition of a distinct form of neurocysticercosis with benign prognosis. 45th Annual Meeting of the American Academy of Neurology, Washington, DC, USA, May 1993.
  16. Platform presentation: Single enhancing CT lesions. VI Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1993.
  17. Platform presentation: Stroke subtypes among hispanics living in Guayaquil, VI Ecuadorian Congress of Neurology, Guayaquil, May 1993.
  18. Poster presentation: Takayasu’s disease: analysis of seven patients. XVII Sudamerican Congress of Cardiology, Cartagena de Indias, Colombia, August 1995.
  19. Platform presentation: Ischemic cerebrovascular complications of Takayasu’s disease. VII Ecuadorian Congress of Neurology, Quito, Ecuador, September 1995.
  20. Platform presentation: Angiographic findings in Ecuadorian mestizos with anterior circulation occlusive cerebrovascular disease. VII Ecuadorian Congress of Neurology, Quito, Ecuador, September 1995.
  21. Platform presentation: Primary intraventricular hemorrhage: analysis of prognostic factors in 25 patients. VII Ecuadorian Congress of Neurology, Quito, Ecuador, September 1995.
  22. Poster presentation: Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 15 patients. 48th Annual Meeting of the American Academy of Neurology, San Francisco, CA, USA, March 1996.
  23. Poster presentation: Nontraumatic intracerebral hemorrhage in young adults: Analysis of 151 patients. XVI World Congress of Neurology, Buenos Aires, Argentina, September 1997.
  24. Poster presentation: Dolichoectatic vertebrobasilar artery: Review of 27 cases. XVI World Congress of Neurology, Buenos Aires, Argentina, September 1997.
  25. Poster presentation: History of human cysticercosis. XVI World Congress of Neurology, Buenos Aires, Argentina, September 1997.
  26. Poster presentation: Pontine hemorrhages: analysis of 52 patients. I Hispanoamerican Congress of Cerebrovascular Diseases, Guayaquil, Ecuador, October 1998
  27. Poster presentation: Cerebellar hemorrhages. I Hispanoamerican Congress of Cerebrovascular Diseases, Guayaquil, Ecuador, October 1998
  28. Poster presentation: Angiographic findings in Ecuadorian mestizos with anterior circulation occlusive cerebrovascular disease. I Hispanoamerican Congress of Cerebrovascular Diseases, Guayaquil, Ecuador, October 1998
  29. Poster presentation: Intracranial hemorrhages in primary tumors of the central nervous system: analysis of prognostic factors in 14 patients. XXVIII Latinamerican Congress of Neurosurgery, Santiago de Chile, Chile, October 1998
  30. Platform presentation: Pontine hemorrhage: analysis of prognostic factors in 51 patients. XX Congress of Medicine, Surgery, and Specialities, Luis Vernaza Hospital, Guayaquil, Ecuador, November 1998
  31. Poster presentation: Primary intraventricular hemorrhages. 51th Annual Meeting of the American Academy of Neurology, Toronto, Canada, April 1999.
  32. Poster presentation: Cerebrovascular complications of snake bites. V Congress of the Iberoamerican Society of Cerebrovascular Disease, Santo Domingo, Dominican Republic, September 2002.
  33. Poster presentation: Are lacunar strokes different in hispanic patients? The SPS3 study. 18th European Stroke Conference, Stockholm, Sweden, May 2009.
  34. Poster presentation: Profile of 7519 neurologic outpatients in Guayaquil, Ecuador. 64th Annual Meeting of the American Academy of Neurology, New Orleans, US, April 2012
  35. Poster presentation: calcified neurocysticercosis among patients with primary headache. 64th Annual Meeting of the American Academy of Neurology, New Orleans, US, April 2012
  36. Poster presentation: Subjective sleep quality and insomnia: correlation with cardiovascular health status in community-dwelling elders living in rural coastal Ecuador – The Atahualpa Project. 66th Annual Meeting of the American Academy of Neurology, Philadelphia, US, April 2014
  37. Poster presentation: Comparing cognitive screening tools in a rural Ecuadorian population: The Atahualpa Project. 66th Annual Meeting of the American Academy of Neurology, Philadelphia, US, April 2014
  38. Poster presentation: cerebral microbleeds. 67th Annual Meeting of the American Academy of Neurology, Washington DC, US, April 2015
  39. Poster presentation: feasibility of sleep studies in developing countries. 67th Annual Meeting of the American Academy of Neurology, Washington DC, US, April 2015

Profesor Invitado A Congresos (Conferencias Magistrales)

  1. Therapy of neurocysticercosis. Course Update on Neurocysticercosis, National Institute of Neurology and Neurosurgery of Mexico, Mexico DF, Mexico, March 1988.
  2. Diagnosis and treatment of neurocysticercosis. 1st Congress of Medicine and Surgery of the Gustavo Baz Hospital, Netzahualcoyotl, Mexico, October 1988.
  3. 1st Course of Neuropsychology of the Mexican Society of Audiology, Mexico DF, Mexico, November 1988.
  4. XXVIII National Congress of Surgeons Mexico DF, Mexico, November 1988.
  5. V Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1991.
  6. Tropical Spastic Paraparesis, XIV Annual Meeting of the Association of Physicians of the National Institute of Neurology and Neurosurgery of Mexico, Acapulco, Mexico, December 1991.
  7. Angiitis of the central nervous system. VI Ecuadorian Congress of Neurology, Guayaquil, Ecuador, May 1993.
  8. Management of Neurocysticercosis. IV International Course of Neuropediatric, Quito, Ecuador, July 1993.
  9. Recent advances in the treatment of neurocysticercosis. XVI Annual Meeting of the Association of Physicians of the National Institute of Neurology and Neurosurgery of Mexico, Mazatlan, Mexico, September 1993.
  10. Epilepsy due to neurocysticercosis. VII Ecuadorian Congress of Neurology, Quito, Ecuador, September 1995.
  11. Cysticercosis: importance as a cause of morbidity and current concepts of clinical management. Informal consultation of cysticercosis, sponsored by the P.A.H.O. Brasilia, Brazil, August 1995.
  12. Cysticercosis and epilepsy. IX Panamerican Congress of Neurology, Guatemala city, Guatemala, October 1995.
  13. Diagnostic criteria for cysticercosis. 48th Annual Meeting of the American Academy of Neurology, San Francisco, CA, USA, March 1996.
  14. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. I International Symposium on Cysticercosis, Lima, Perú, May 1996.
  15. Cysticercosis in the acute encephalitic phase. I International Symposium on Cysticercosis, Lima, Perú, May 1996.
  16. Epilepsy due to neurocysticercosis. I International Symposium on Cysticercosis, Lima, Perú, May 1996.
  17. Epidemiology of stroke in Hispanics. Presented before the Stroke team of the Department of Neurology, University of Texas at Houston, Houston, TX, USA, June 1996.
  18. Grands Rounds of the University of Texas at Houston, Houston, TX, USA, June 1996.
  19. Cysticercosis in Ecuadorian children. 2nd International Symposium of Neurocysticercosis in Childhood “Tanya Martinez Flisser”, México city, México, August 1996.
  20. Control of Taeniosis/Cysticercosis in Ecuador. 2nd International Symposium of Neurocysticercosis in Childhood “Tanya Martinez Flisser”, México city, México, August 1996.
  21. Recent advances in the diagnosis and management of neurocysticercosis. Presented at the Symposium: Neurocysticercosis an emerging public health problem, Sponsored by the CDC and NIH, Boston, MA, USA, April 1997.
  22. Diagnostic criteria for cysticercosis. VIII Ecuadorian Congress of Neurology, Guayaquil, Ecuador, July 1997.
  23. How to write a scientific paper. XVI World Congress of Neurology, Buenos Aires, Argentina, September 1997.
  24. XVI World Congress of Neurology, Buenos Aires, Argentina, September 1997.
  25. Differential diagnosis of vascular dementia. International Course on Alzheimer’s Disease. Pamplona, Spain, November 1997.
  26. Intracranial hemorrhages in young adults. I Hispanoamerican Congress of Cerebrovascular Diseases, Guayaquil, Ecuador, October 1998
  27. Racial differences in stroke subtypes. I Hispanoamerican Congress of Cerebrovascular Diseases, Guayaquil, Ecuador, October 1998
  28. Infections of the nervous system. XX Congress of Medicine, Surgery, and Specialities, Luis Vernaza Hospital, Guayaquil, Ecuador, November 1998
  29. How to write a paper. Presented before the National Institute of Neurology and Neurosurgery of Mexico, Mexico D.F., Mexico, February 1999.
  30. Presentation, diagnosis, subtypes and diagnostic criteria for cysticercosis. Symposium Cysticercosis and Epilepsy presented by the University of Southern California School of Medicine, Glendale, CA, USA, May 1999.
  31. Medical therapy for cysticercosis: albendazole and praziquantel. Symposium Cysticercosis and Epilepsy presented by the University of Southern California School of Medicine, Glendale, CA, USA, May 1999.
  32. Controversies of treatment and the development of a treatment algorithm for cysticercosis. Symposium Cysticercosis and Epilepsy presented by the University of Southern California School of Medicine, Glendale, CA, USA, May 1999.
  33. Stroke in South America. II Iberoamerican Congress of Cerebrovascular Disease, Mexico City, Mexico, September 1999.
  34. Infections and stroke. II Iberoamerican Congress of Cerebrovascular Disease, Mexico City, Mexico, September 1999.
  35. Therapy of neurocysticercosis. X Panamerican Congress of Neurology, Cartagena de Indias, Colombia, October 1999
  36. Cerebrovascular complications of infectious diseases: X Panamerican Congress of Neurology, Cartagena de Indias, Colombia, October 1999.
  37. Peruvian Congress of Neurology, Lima, Perú, November 1999.
  38. Present and future of cerebrovascular disease in the Americas, III Iberoamerican Congress of Cerebrovascular Disease, La Habana, Cuba, September 2000.
  39. Tropical causes of stroke. III Iberoamerican Congress of Cerebrovascular Disease, La Habana, Cuba, September 2000.
  40. N Presented before the Dominican Society of Neurology. Santo Domingo, Dominican Republic, November 2000.
  41. Medical publications in Spanish. IX Course in Spanish of the American Academy of Neurology, Miami, Fl, USA, November 2000.
  42. Diagnosis of neurocysticercosis. 49th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Houston, TX, USA, November 2000.
  43. 53rd Annual Meeting of the American Academy of Neurology, Philadelphia, PA, USA, May 2001.
  44. Infections and stroke. X European Stroke Conference. Lisbon, Portugal, May 2001
  45. XVII World Congress of Neurology, London, England, June 2001.
  46. XIII Colombian Congress of Neurology, Cartagena, Colombia, October 2001.
  47. Cerebrovascular complications of infectious diseases. XXIII International Meeting of Internal Medicine, Lima, Perú, October 2001.
  48. Classification and management of intracranial hemorrhages. XXIII International Meeting of Internal Medicine, Lima, Perú, October 2001.
  49. XXIII International Meeting of Internal Medicine, Lima, Perú, October 2001.
  50. Neurological complications of infective endocarditis. Ecuadorian Congress of Cardiology, Guayaquil, Ecuador, October 2001.
  51. Intracranial hemorrhages: classification and management. IV Iberoamerican Congress of Cerebrovascular Disease. San Pedro Sula, Honduras, November 2001
  52. The ischemic penumbra. IV Iberoamerican Congress of Cerebrovascular Disease. San Pedro Sula, Honduras, November 2001.
  53. Grand Rounds of the University of Texas at San Antonio, San Antonio, TX, USA, January 2002.
  54. Cysticercosis and other parasitic diseases of the nervous system. 54th Annual Meeting of the American Academy of Neurology, Denver, CO, USA, April 2002.
  55. Neuroimaging findings in neurocysticercosis. WHO Symposium of Taeniosis/cysticercosis in Africa, Arusha, Tanzania, August 2002.
  56. Neurocysticercosis, VIII International Course of Neurosciences of the National Institute of Neurological Sciences Oscar Trelles Montes, Lima, Perú, August 2002
  57. Cerebrovascular complications of infective endocarditis. V Iberoamerican Congress of Cerebrovascular Disease, Santo Domingo, Dominican Republic, September 2002.
  58. Tropical causes of cerebrovascular disease. V Iberoamerican Congress of Cerebrovascular Disease, Santo Domingo, Dominican Republic, September 2002.
  59. Proposal for a multicentric neuroepidemiological stroke study in Latin America, V Iberoamerican Congress of Cerebrovascular Disease, Santo Domingo, Dominican Republic, September 2002.
  60. Treatment of Diabetic Neuropathy. VI Ecuadorian Congress of Nephrology, Guayaquil, Ecuador, October 2002.
  61. How to publish medical papers in Spanish. X Course in Spanish of the American Academy of Neurology, San Juan, Puerto Rico, November 2002.
  62. Neuropathology of cysticercosis. I Workshop on Brain Calcifications and Epileptogenesis of the National Institute of Neurological Sciences Oscar Trelles Montes, Lima, Perú, February 2003
  63. Helminthic infections of the nervous system. 55th Annual Meeting of the American Academy of Neurology, Honolulu, Hawaii, USA, April 2003.
  64. Cysticercosis and Chagas’ disease. 55th Annual Meeting of the American Academy of Neurology, Honolulu, Hawaii, USA, April 2003.
  65. Emerging stroke risk factors. XII European Stroke Conference, Valencia, Spain, May 2003.
  66. Neurocysticercosis, VIII Peruvian Congress of Infectious and Tropical Diseases, Lima, Perú, August 2003
  67. Treatment of intracranial hemorrhages. VI Iberoamerican Congress of Cerebrovascular Disease, San José, Costa Rica, September 2003.
  68. Stroke in South America, VI Iberoamerican Congress of Cerebrovascular Disease, San José, Costa Rica, September 2003
  69. XI Panamerican Congress of Neurology, Santiago de Chile, Chile, October 2003.
  70. Non pharmacological neuroprotection in patients with acute ischemic stroke. XI Panamerican Congress of Neurology, Santiago de Chile, Chile, October 2003.
  71. Stroke in South America. XI Panamerican Congress of Neurology, Santiago de Chile, Chile, October 2003.
  72. Cerebrovascular complications of neurocysticercosis. 52th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, PA, USA, November 2003.
  73. Helminthic infections of the nervous system. 56th Annual Meeting of the American Academy of Neurology, San Francisco, CA, USA, April 2004.
  74. The magnitude of stroke in Latin America. V World Stroke Congreess, Vancouver, Canada, June 2004.
  75. Therapy of intracranial hemorrhage. Ecuadorian Congress of Neurosurgery. Guayaquil, Ecuador. September 2004.
  76. Comunity studies of stroke in Latin America. VII Iberoamerican Congress of Cerebrovascular Diseases, Cancún, Mexico, September 2004.
  77. Cerebral ischemia in subarachnoid hemorrhage and in intracerebral hemorrhage. Mechanisms and therapeutic approaches. XIV European Stroke Conference, Bolonia, Italy, May 2005.
  78. Parasiticidal effect and associated inflammation. Workshop Advances in Cysticercosis of the National Institute of Neurological Sciences Oscar Trelles Montes. Lima, Peru, June 2005
  79. What evidence exists that anti-inflammatory agents decrease symptoms in neurocysticercosis. Workshop Advances in Cysticercosis of the National Institute of Neurological Sciences Oscar Trelles Montes. Lima, Peru, June 2005
  80. Advances in the management of subarachnoid cysticercosis. XI Resident Meeting of the National Institute of Neurological Sciences Oscar Trelles Montes. Lima, Peru, June 2005
  81. Albendazole and praziquantel for therapy of neurocysticercosis: a meta-analysis of randomized, controlled trials. XII Ecuadorian Congress of Neurology, Salinas, Ecuador, July 2005.
  82. The role of the Institutional review board in medical investigation. XII Ecuadorian Congress of Neurology, Salinas, Ecuador, July 2005.
  83. Neurocysticercosis and stroke. XVIII World Congress of Neurology, Sydney, Australia, November 2005.
  84. Neuroimaging of infectious diseases of the nervous system. XVIII World Congress of Neurology, Sydney, Australia, November 2005.
  85. Parasitic infections. 58th Annual Meeting of the American Academy of Neurology, San Diego, CA, USA, April 2006.
  86. Infectious causes of stroke in different geographical areas. XV European Stroke Conference, Brussels, Belgium, May 2006.
  87. Epiediomology of Stroke in Latin America. IX Iberoamerican Congress of Cerebrovascular Diseases, Guatemala City. Guatemala, September 2006
  88. Infectious endocarditis. X Iberoamerican Congress of Cerebrovascular Disease, Lima, Perù, September 2007.
  89. The Challenges of conducting a clinical trial in developing countries. Annual Meeting of SPS3 investigators. San Diego, CA, September 2007.
  90. Annual Meeting of the Infectious Disease Society of North America, San Diego, CA, October 2007
  91. Neuroimaging of infections and stroke. XII Panamerican Congress of Neurology, Santo Domingo, Repùblica Dominicana, October 2007
  92. Parasitic diseases of the nervous system. XII Panamerican Congress of Neurology, Santo Domingo, Repùblica Dominicana, October 2007
  93. Treatment of neurocysticercosis. XII Panamerican Congress of Neurology, Santo Domingo, Repùblica Dominicana, October 2007
  94. Small vessel disease. Epidemiology and risk factors. XII Panamerican Congress of Neurology, Santo Domingo, Repùblica Dominicana, October 2007
  95. Tropical causes of stroke. 60th Annual Meeting of the American Academy of Neurology. Chicago, Ill, April 2008
  96. Neurocysticercosis and other parasitic infections. 60th Annual Meeting of the American Academy of Neurology. Chicago, Ill, April 2008.
  97. Infections and stroke. XX European Stroke Conference, Hamburg, Germany, May 2011.
  98. Is lacunar disease a different disease in Latin America? XXI European Stroke Conference, Lisbon, Portugal, May 2012.
  99. Neurocysticercosis and stroke. VIII World Stroke Congress, Brasilia, Brazil, October 2012.
  100. Infections and stroke. VIII World Stroke Congress, Brasilia, Brazil, October 2012.
  101. Tropical epilepsy. 65th Annual Meeting of the American Academy of Neurology, San Diego, US, April 2013
  102. Neurocysticercosis in non-endemic areas and in the traveler. 65th Annual Meeting of the American Academy of Neurology, San Diego, US, April 2013
  103. Neurocysticercosis and epilepsy. 66th Annual Meeting of the American Academy of Neurology, Philadelphia, US, April 2014
  104. Neurocysticercosis and epilepsy. Grand Rounds University of Loyola, April 2015.